Wrapped Health

Connects provider recommendations for OTC products and health services with digital purchasing and fulfillment.

Cover Block

Publicly reported

Field	Value
Name	Wrapped Health
Tagline	Connects provider recommendations for OTC products and health services with digital purchasing and fulfillment. [Wrapped Health, Unknown]
Headquarters	Washington, D.C., United States [Citybiz, October 2026]
Stage	Pre-seed [Wrapped Health, October 2026]
Business Model	B2B2C
Industry	Healthtech
Technology	AI / Machine Learning [Wrapped Health, Unknown]
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder
Founder	Max Russell-Harris [Wrapped Health, Unknown]
Funding Label	Pre-seed
Total Disclosed Funding	~$2,100,000 [Wrapped Health, October 2026]

Summary and Signal

PUBLIC Wrapped Health connects provider recommendations for over-the-counter health products to digital purchasing and fulfillment inside the clinical workflow, and it merits investor attention now because it has already secured an athenahealth marketplace distribution point and announced a $2.1 million pre-seed round in October 2026 [Wrapped Health, June 2026] [Wrapped Health, October 2026] [Morningstar / PR Newswire, October 2026]. The company is based in Washington, D.C., and public materials position it around a simple but commercially relevant gap in care delivery: clinicians often recommend consumer health products, but the handoff from recommendation to purchase is fragmented and poorly tracked [Citybiz, October 2026] [Wrapped Health].

The product allows providers to recommend products from within the EHR and send patients a secure purchasing link, with Wrapped stating that the initial rollout begins through athenahealth and is available through the athenahealth Marketplace to more than 180,000 clinicians on the athenaOne network [Wrapped Health, June 2026] [Dealroom.co] [Morningstar / PR Newswire, October 2026]. Its differentiation, based on current public evidence, rests less on a novel commerce layer than on workflow placement inside care delivery, plus claimed AI support for matching products to patient care plans and the potential to use FSA or HSA funds for qualifying purchases [Wrapped Health] [Wrapped Health, Unknown] [Citybiz, October 2026].

Publicly available team evidence is still fairly thin, which is typical at this stage. Max Russell-Harris is identified in company materials and online profiles as founder and CEO, while the company also lists a set of clinical and industry advisors that includes Dr. Wayne Batchelor, Mel Hall, Shiv Gaglani, and Colin Dyer, which adds some signal around healthcare and operating credibility even if operating depth inside the core team is not yet well documented in public sources [Wrapped Health, Unknown] [LinkedIn, Retrieved 2026] [Wayne Batchelor, MD, MHS, MBA - President, Medicine Service Line, Inova Health System/Schar Chair Inova Heart and Vascular/ Past-Chair ACC IC Section/Vice Chair, STS/ACC TVT Registry/ Professor of Medicine, Duke University/FDA consultant | LinkedIn, Retrieved 2026].

On capitalization, the disclosed picture is straightforward: Wrapped announced a $2.1 million pre-seed round co-led by Lightbank VC and Arteria Capital, with a B2B2C model aimed at independent practices, health systems, and digital health platforms rather than direct-to-consumer acquisition [Wrapped Health, October 2026] [Morningstar / PR Newswire, October 2026] [Citybiz, October 2026]. Arteria also brings sector adjacency through founder Russell Glass, whose public background includes prior leadership at Headspace and Ginger and earlier company-building experience at Bizo [Arteria Capital] [LinkedIn, Retrieved 2026].

The next 12 to 18 months will likely matter more for proof of adoption than for product storytelling. Investors should watch for evidence that athenahealth access converts into named provider customers, broader EHR integrations, repeatable usage across care pathways such as postpartum and chronic-condition management, and clearer proof that the workflow improves conversion or patient follow-through rather than simply digitizing a recommendation step [Wrapped Health, June 2026] [Wrapped Health, October 2026] [Citybiz, October 2026].

No independent source found -- This section relies materially on company announcements and company website claims, with partial corroboration from Citybiz, Morningstar / PR Newswire, Dealroom.co, and LinkedIn.

Taxonomy Snapshot

Axis	Value
Stage	Pre-seed
Business Model	B2B2C
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	$2.1 million disclosed pre-seed [Wrapped Health, October 2026]

Company Overview

PUBLIC Wrapped Health is a Washington, D.C.-based healthtech startup focused on a narrow but recognizable workflow gap: clinicians often recommend over-the-counter products or adjacent consumer health services, but the handoff from recommendation to purchase usually happens outside the clinical record and without much follow-through [Wrapped Health] [Crunchbase]. The company presents itself as a B2B2C platform that lets providers send those recommendations from within the electronic health record, beginning with an athenahealth integration that the company said went live in June 2026 [Wrapped Health, June 2026] [Wrapped Health] [Crunchbase].

The public record on formation is still thin. Crunchbase identifies the company as Wrapped Health and lists Washington, D.C. as headquarters, while the company site describes the product as "Recommend OTC products from the EHR" and frames the service around extending care beyond the visit [Crunchbase] [Wrapped Health]. Public materials reviewed here do not establish a founding date or legal entity name, so chronology has to rest on confirmed operating milestones rather than an origin story.

The clearest milestone sequence starts with the June 2026 announcement that Wrapped Health was live with athenahealth, followed by the October 2026 announcement of a $2.1 million pre-seed round led by Lightbank VC and Arteria Capital [Wrapped Health, June 2026] [Wrapped Health, October 2026] [Crunchbase]. On the evidence available, the company is early but already tied to a concrete distribution channel, which matters more at this stage than broad narrative claims about category creation [Wrapped Health, October 2026] [Wrapped Health].

One source, partially checked -- Confirmed primarily by company website materials, with partial corroboration from Crunchbase.

The Product and the Stack

Core product

MIXED The product is easiest to understand as an EHR-embedded recommendation and checkout workflow, not as a standalone consumer storefront. Wrapped Health says clinicians can recommend over-the-counter products from within the chart, then send patients a secure purchasing link so they can buy the recommended items without leaving the care context entirely [Wrapped Health, Unknown] [Wrapped Health, June 2026]. The company’s homepage and June 2026 launch announcement both point to the same operating sequence: chart-based product selection, a secure patient link, and documentation flowing back into the athenaOne record [Wrapped Health, Unknown] [Wrapped Health, June 2026].

The public product surface is also fairly specific about what problem it is trying to remove from clinical teams. Wrapped describes the experience as allowing practices to extend care beyond the visit while skipping follow-up calls tied to product recommendations, and its homepage shows example categories such as medication companions, lab companions, and PCOS support [Wrapped Health, Unknown]. A separate company essay says the platform uses AI to help care teams identify products that support a patient’s care plan and send personalized recommendations, but that claim remains company-sourced and the underlying model design, data inputs, and review workflow are not described in public materials [Wrapped Health, Unknown].

Distribution and implementation

MIXED The key technical wedge in public evidence is the athenahealth integration. Wrapped announced in June 2026 that it was live with athenahealth, and later funding coverage said the product was available through the athenahealth Marketplace to more than 180,000 clinicians on the athenaOne network [Wrapped Health, June 2026] [Dealroom.co] [Morningstar / PR Newswire, October 2026]. That does not establish active usage across that base, but it does show the company chose distribution through existing clinical software rather than asking providers to adopt a separate workflow from scratch [Wrapped Health, June 2026] [Morningstar / PR Newswire, October 2026].

The implementation story stays narrow in the public record, which is useful in its own way. Wrapped has publicly said it plans to add integrations with other EHR systems and build partnerships with provider organizations, health systems, and digital-health platforms, but only the athenahealth integration is actually confirmed today [Wrapped Health, October 2026] [Citybiz, October 2026]. Public materials also say patients can use eligible FSA or HSA benefits for qualifying purchases, which suggests some attention to payment eligibility and checkout design, though the sources do not detail claims adjudication, merchant-of-record structure, or fulfillment mechanics [Citybiz, October 2026] [Wrapped Health, Unknown].

One source, partially checked -- Core workflow is corroborated by the company homepage and June 2026 launch post, while AI functionality and several operational details remain company-only; the athenahealth distribution claim is supported by company materials and press coverage [Wrapped Health, Unknown] [Wrapped Health, June 2026] [Morningstar / PR Newswire, October 2026].

The Market They Are Entering

Publicly reported The market matters now because Wrapped Health sits at the intersection of three established spending pools, digital health software, electronic health record distribution, and consumer out-of-pocket healthcare purchases, even though the company itself has not yet cited a third-party market size study [Morningstar / PR Newswire, October 2026] [Wrapped Health, June 2026].

The public record does not support a direct TAM, SAM, or SOM for Wrapped Health, so the cleaner approach is to anchor on analogous markets rather than force precision the sources do not provide. On the software side, Wrapped is distributing through the athenahealth Marketplace and said in June 2026 that it was live with athenahealth, with later coverage stating availability to more than 180,000 clinicians through that channel [Wrapped Health, June 2026] [Dealroom.co]. That does not establish adoption, revenue, or active usage, but it does define the first credible distribution surface: ambulatory clinical workflows where providers already document care and can add recommendations without leaving the chart [Wrapped Health, Unknown] [Citybiz, October 2026].

Demand drivers are fairly clear from the product design. Wrapped is trying to reduce a common gap between a clinician recommending an over-the-counter product and a patient actually finding and purchasing it, with the company describing a secure purchasing link sent from within the visit workflow [Wrapped Health, June 2026] [Wrapped Health, Unknown]. The cited use cases, pregnancy, postpartum care, chronic-condition management, and post-surgical recovery, are all categories where care plans often extend beyond prescribed drugs and include supplements, monitors, braces, wound care, or other consumer products that are purchased outside the clinic and outside the pharmacy benefit [Citybiz, October 2026] [Wrapped Health, Unknown].

A second tailwind is the continued normalization of consumer-pay healthcare. Wrapped says patients can use eligible FSA or HSA funds for qualifying purchases, which matters because it ties recommendations to an existing payment behavior rather than asking providers to stock products or patients to submit reimbursement paperwork after the fact [Citybiz, October 2026]. The adjacent markets here are therefore not limited to clinical software. They also include digital pharmacy and fulfillment workflows, cash-pay commerce in healthcare, and patient engagement tools that turn care-plan instructions into transactions or next steps, even if Wrapped is positioning itself more narrowly around OTC and everyday health products [Wrapped Health, October 2026] [Wrapped Health, Unknown].

Regulatory and macro forces cut both ways. On the constructive side, providers and health systems continue to look for lower-friction ways to support patient adherence outside the exam room, while EHR marketplaces offer a practical route to distribution without a long standalone deployment cycle [Wrapped Health, June 2026] [Morningstar / PR Newswire, October 2026]. The limiting factor is that healthcare commerce touching patient recommendations, benefits eligibility, and workflow integrations can carry compliance, clinical governance, and procurement scrutiny; the current sources do not show how Wrapped handles those issues beyond product-level descriptions on its own site [Wrapped Health, Unknown].

Market lens	What public sources support	Relevance to Wrapped
EHR distribution channel	Availability to more than 180,000 clinicians through the athenahealth Marketplace [Dealroom.co]	Defines the first reachable clinician audience, not adoption
OTC recommendation workflow	Product allows providers to recommend OTC products from the EHR and send secure purchasing links [Wrapped Health, June 2026] [Wrapped Health, Unknown]	Suggests demand where care plans include consumer products
Consumer-pay healthcare spend	Eligible FSA/HSA funds can be used for qualifying purchases [Citybiz, October 2026]	Supports a payment path for out-of-pocket health purchases
Provider expansion path	Company said it plans additional EHR integrations and partnerships with provider organizations, health systems, and digital-health platforms [Morningstar / PR Newswire, October 2026]	Expands the analogous market beyond a single marketplace

The table shows why the market case is plausible but still early. The strongest public signal is not a measured market size; it is a distribution wedge into a large clinician network, paired with a workflow aimed at turning recommendations into completed purchases.

One source, partially checked -- Relies on one independent publisher report and company materials for market analogs; no third-party TAM/SAM/SOM study was identified in the public sources used.

The Competitive Field

MIXED Wrapped Health is positioning itself less against a single branded rival than against the default workflow of verbal OTC recommendations, after-visit staff follow-up, and generic patient self-service inside large EHR ecosystems [Wrapped Health, Unknown] [Wrapped Health, June 2026].

The competitive map is easiest to read by separating infrastructure from workflow. On one side sit incumbent EHR platforms, with athenahealth the only confirmed channel here, because Wrapped is already live in the athenahealth Marketplace and available to more than 180,000 clinicians through the athenaOne network [Wrapped Health, June 2026] [Dealroom.co]. Those incumbents control clinician attention, chart context, and integration rules. On another side sit challenger digital-health companies and provider enablement tools that may address adjacent needs such as patient engagement, referrals, remote care plans, or commerce, but no named direct rival is established in the sourced record. The third category is the substitute that matters most in practice: clinicians or care teams recommending products manually, with the patient then buying on Amazon, at a pharmacy, or not at all. That substitute is fragmented, but it is deeply entrenched because it requires no procurement cycle and no new software budget [Wrapped Health, Unknown] [Wrapped Health, June 2026].

Wrapped Health appears to have one concrete edge today, and it is distribution rather than category ownership. The June 2026 athenahealth launch and the later claim of availability to more than 180,000 clinicians give the company a real wedge into clinical workflow, which is harder to replicate than a standalone checkout flow or a generic recommendation engine [Wrapped Health, June 2026] [Dealroom.co]. Still, the durability of that edge looks perishable rather than structural. The product sits inside a channel controlled by athenahealth, and the current public record does not establish exclusive access, exclusive data rights, or a regulatory moat around OTC recommendation and fulfillment. The AI positioning may help relevance and personalization, but the cited support for that claim is company-authored, so it should be treated as a product direction rather than a verified moat [Wrapped Health, Unknown].

The company is most exposed to two better-resourced classes of competitor, even if the sources do not name a direct startup rival. First, athenahealth itself, as the confirmed distribution partner, has the platform advantage if commerce-linked recommendations become strategically important inside the EHR. Second, broader patient-commerce or care-navigation products could approach the problem from outside the chart and still capture patient spend, especially if they own stronger consumer acquisition or broader fulfillment relationships. Wrapped also looks channel-constrained today. Public evidence ties initial distribution to athenahealth, while expansion to additional EHRs and provider partnerships remains a stated plan rather than an observed footprint [Morningstar / PR Newswire, October 2026] [Citybiz, October 2026]. That matters because a workflow business without multi-EHR reach can win niche adoption and still struggle to become system infrastructure.

The most plausible 18-month scenario is a channel race rather than a pure product race. Winner if X: athenahealth, if clinician demand for embedded OTC recommendation rises and the marketplace keeps producing viable point solutions, because the platform then compounds its role as gatekeeper to workflow distribution [Wrapped Health, June 2026] [Dealroom.co]. Loser if Y: Wrapped Health, if it cannot convert its initial athenahealth presence into either measurable provider adoption or additional EHR integrations, because the current public case rests heavily on access to clinicians rather than disclosed evidence of active usage, customer breadth, or downstream retention [Morningstar / PR Newswire, October 2026] [Wrapped Health, October 2026]. The more constructive counter-scenario is that Wrapped becomes the specialist layer that EHRs prefer to partner with rather than build, but the public evidence is not yet strong enough to call that the base case.

One source, partially checked -- This section is grounded in public company materials, Dealroom coverage, and press-release reporting, but no named direct competitors are confirmed in the sourced record and several competitive inferences rely on channel structure rather than independent market mapping.

Opportunity

PUBLIC The prize here is straightforward: if Wrapped Health can become the default transaction layer for provider-recommended consumer health products inside the EHR, it could sit on a large and recurring flow of patient purchases that today is fragmented, offline, or lost after the visit [Wrapped Health, June 2026] [Wrapped Health, October 2026].

The headline opportunity is not that Wrapped becomes another digital storefront. It is that it becomes embedded clinical-commerce infrastructure, the software layer that turns a provider recommendation into a completed, trackable purchase without asking the practice to manage inventory or a separate workflow [Wrapped Health, June 2026] [Wrapped Health, Unknown]. That outcome is at least reachable on the current public record because the company already has a live athenahealth integration and says it is available through the athenahealth Marketplace to more than 180,000 clinicians on the athenaOne network, which gives it a meaningful distribution wedge early in its life [Wrapped Health, June 2026] [Dealroom.co]. The October 2026 pre-seed round, co-led by Lightbank VC and Arteria Capital, matters less for the dollar amount than for what management said it would fund: additional EHR integrations and partnerships with provider organizations, health systems, and digital-health platforms [Wrapped Health, October 2026] [Morningstar / PR Newswire, October 2026].

The upside branches into a few distinct scale paths, and each depends on execution rather than category creation from scratch.

Scenario	What happens	Catalyst	Why it's plausible
EHR commerce standard	Wrapped becomes the default add-on inside major ambulatory EHRs for OTC and care-adjacent product recommendations, starting from athenahealth and expanding to additional systems	Successful expansion beyond the initial athenahealth deployment into other EHR integrations the company has publicly said it plans to pursue [Wrapped Health, October 2026]	The product is already live in athenahealth and available via its Marketplace, which suggests an initial distribution channel is established rather than theoretical [Wrapped Health, June 2026] [Dealroom.co]
Condition-specific care pathway engine	Wrapped wins repeat usage in categories like pregnancy, postpartum care, chronic-condition management, and post-surgical recovery, then packages those workflows for provider groups and digital health platforms	Demonstrated adoption in the use cases the company already cites publicly, combined with partner distribution into provider organizations and digital-health platforms [Citybiz, October 2026] [Wrapped Health, October 2026]	Public materials already frame these as core use cases, and the product flow shown on the site is built around chart-linked recommendations and secure patient checkout [Wrapped Health, Unknown] [Wrapped Health, Unknown]
Benefits-aware consumer health rail	Wrapped becomes a preferred way to route medically relevant purchases that can use FSA or HSA funds, improving conversion on provider recommendations and creating a differentiated patient experience	Product refinement around qualifying purchases and payer-benefit workflows, plus broader provider adoption [Citybiz, October 2026]	The company already says patients can use eligible FSA or HSA benefits for qualifying purchases, which gives it a practical wedge beyond generic ecommerce [Citybiz, October 2026]

What compounding looks like is a distribution and conversion flywheel. Each new EHR or marketplace integration increases the number of clinicians who can send recommendations from within the chart, and each additional use case gives providers more reasons to keep the workflow inside normal care delivery rather than handing patients verbal instructions that may never convert to purchases [Wrapped Health, June 2026] [Wrapped Health, Unknown]. If Wrapped can show that an in-workflow recommendation plus secure checkout raises adherence or patient follow-through, the product becomes easier to sell to adjacent provider groups and digital-health platforms; if more clinicians use it, the company should also gain a larger body of data on which products are recommended in which clinical contexts, which is relevant because the company says it uses AI to help care teams identify products that support a patient care plan and send personalized recommendations [Wrapped Health, Unknown]. The early sign that this flywheel may be starting is modest but real: the company is already live on one large clinical network rather than still selling an integration roadmap [Wrapped Health, June 2026] [Dealroom.co].

The size of the win is still hard to pin down from public data because no independent market sizing or revenue base is in the record. The cleanest way to frame the upside is through infrastructure position rather than a near-term financial model. If Wrapped becomes a meaningful embedded layer across EHR-connected outpatient care, with multiple integrations and recurring transaction volume from provider-recommended purchases, it could resemble the kind of workflow infrastructure asset that draws strategic interest from EHR vendors, digital-health platforms, benefits players, or healthcare commerce networks (scenario, not a forecast) [Wrapped Health, October 2026] [Morningstar / PR Newswire, October 2026]. Public evidence does not yet support a valuation range, but the operating logic is clear: a company that controls high-intent clinical recommendation flow at the point of care has a chance to own a valuable junction between software distribution, patient commerce, and care-plan follow-through [Wrapped Health, June 2026] [Wrapped Health, Unknown].

No independent source found -- This section relies heavily on company materials and press-release-based coverage, with limited independent public corroboration beyond the financing announcement and athenahealth Marketplace availability.

Sources